BARINTHUS BIOTHERAPEUTICS PLC Share Price Today: Live Updates & Key Insights
BARINTHUS BIOTHERAPEUTICS PLC share price today is $0.63, up 0%. The stock opened at $0.63 against the previous close of $0.63, with an intraday high of $0.63 and low of $0.6239.
BARINTHUS BIOTHERAPEUTICS PLC Share Price Chart
BARINTHUS BIOTHERAPEUTICS PLC
BARINTHUS BIOTHERAPEUTICS PLC Share Price Performance
BARINTHUS BIOTHERAPEUTICS PLC Institutional Holdings
BARINTHUS BIOTHERAPEUTICS PLC Market Status
BARINTHUS BIOTHERAPEUTICS PLC Fundamentals
Market Cap 25.72 M
PB Ratio 0.3045
PE Ratio 0.0
Enterprise Value -36.98 M
Total Assets 98.17 M
Volume 5641
BARINTHUS BIOTHERAPEUTICS PLC Company Financials
About BARINTHUS BIOTHERAPEUTICS PLC & investment objective
Company Information Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antigen-specific immune tolerance candidate, which is in Phase I clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease; and VTP-300, an immunotherapy, which is in Phase II clinical trial for the treatment of chronic hepatitis B virus infection. It has a license agreement with Oxford University Innovation for the development and commercialization of products with thermo-responsive adjuvant scaffolds; and U.S. National Institutes of Health for the evaluation of synthetic and polymer-based vaccine technology to prevent infectious disease and treat cancer in animal models. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is based in Germantown, Maryland.
Organisation Biotechnology
Employees 105
Industry Biotechnology
CEO Mr. William J. Enright MBA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
BARINTHUS BIOTHERAPEUTICS PLC FAQs
What is the share price of BARINTHUS BIOTHERAPEUTICS PLC today?
The current share price of BARINTHUS BIOTHERAPEUTICS PLC is $0.63.
Can I buy BARINTHUS BIOTHERAPEUTICS PLC shares in India?
Yes, Indian investors can buy BARINTHUS BIOTHERAPEUTICS PLC shares by opening an international trading and demat account with Motilal Oswal.
How to buy BARINTHUS BIOTHERAPEUTICS PLC shares in India?
You can easily invest in BARINTHUS BIOTHERAPEUTICS PLC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy BARINTHUS BIOTHERAPEUTICS PLC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of BARINTHUS BIOTHERAPEUTICS PLC.
Can I buy fractional shares of BARINTHUS BIOTHERAPEUTICS PLC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of BARINTHUS BIOTHERAPEUTICS PLC?
BARINTHUS BIOTHERAPEUTICS PLC has a market cap of $25.72 M.
In which sector does BARINTHUS BIOTHERAPEUTICS PLC belong?
BARINTHUS BIOTHERAPEUTICS PLC operates in the Biotechnology sector.
What documents are required to invest in BARINTHUS BIOTHERAPEUTICS PLC stocks?
To invest, you typically need:
What is the PE and PB ratio of BARINTHUS BIOTHERAPEUTICS PLC?
The PE ratio of BARINTHUS BIOTHERAPEUTICS PLC is N/A and the PB ratio is 0.30.